Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Endothelin antagonist from Teikoku Hormone inhibits intimal hyperplasia

March 31, 1998

Potent and selective PDE III inhibitor in development at Otsuka

March 31, 1998

New taxanes reverse MDR in breast cancer cells

March 31, 1998

P&U develops antidiabetic amino- and diaminoguanidines

March 31, 1998

New antiplatelet and antithrombotic agent characterized by Taisho

March 31, 1998

Moguisteine, a potential agent for treating allergic cough

March 31, 1998

Melatonin may be involved in the hypnotic activity of zaleplon

March 31, 1998

Japanese scientists develop potent, orally active antihypertensive agent

March 31, 1998

Sumitomo presents new NHE inhibitor with neuroprotective effects

March 31, 1998

New peripheral vasodilator from Otsuka profiled at recent meeting

March 31, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...